Header Logo

Connection

SEAN HARTIG to Immunotherapy, Adoptive

Back to Details
This is a "connection" page, showing publications SEAN HARTIG has written about Immunotherapy, Adoptive.
SEAN HARTIG
Connection Strength
0.078
Immunotherapy, Adoptive
  1. Chimeric antigen receptor (CAR) T cells targeting a pathogenic MHC class II:peptide complex modulate the progression of autoimmune diabetes. J Autoimmun. 2019 01; 96:50-58.
    View in: PubMed
    Score: 0.078
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.